13F HOLDINGS REPORT
ACORN CAPITAL ADVISORS, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001636587-26-000005
Total Value
$295.1M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | TERN | 1,746,264 | $70.5M | 23.90% |
| 2 | CG ONCOLOGY INC | CGON | 1,131,501 | $47.0M | 15.92% |
| 3 | UROGEN PHARMA LTD | URGN | 1,448,420 | $33.9M | 11.49% |
| 4 | TREVI THERAPEUTICS INC | TRVI | 2,144,844 | $26.9M | 9.10% |
| 5 | PUMA BIOTECHNOLOGY INC | PBYI | 4,131,299 | $24.6M | 8.33% |
| 6 | CANDEL THERAPEUTICS INC | CADL | 2,580,517 | $14.6M | 4.94% |
| 7 | CYBIN INC | HELP | 1,573,023 | $12.9M | 4.36% |
| 8 | VERASTEM INC | VSTM | 1,469,153 | $11.3M | 3.84% |
| 9 | BICARA THERAPEUTICS | BCAX | 643,382 | $10.8M | 3.67% |
| 10 | PROTARA THERAPEUTICS INC | TARA | 1,752,115 | $9.3M | 3.16% |
| 11 | ONKURE THERAPEUTICS INC | OKUR | 2,839,674 | $8.2M | 2.79% |
| 12 | CARDIF ONCOLOGY INC | CRDF | 1,962,084 | $5.5M | 1.87% |
| 13 | ATHIRA PHARMA INC. | 04746L203 | 501,739 | $3.8M | 1.29% |
| 14 | JASPER THERAPEUTICS | JSPRW | 1,786,492 | $3.3M | 1.11% |
| 15 | AURA BIOSCIENCES INC | AURA | 595,744 | $3.2M | 1.10% |
| 16 | WHITEHAWK THERAPEUTICS INC | WHWK | 1,139,363 | $2.8M | 0.93% |
| 17 | BIOATLA INC | BCAB | 4,835,111 | $2.8M | 0.93% |
| 18 | Q32 BIO INC. | QTTB | 493,425 | $1.6M | 0.56% |
| 19 | X4 PHARMACEUTICALS INC | XFOR | 273,349 | $1.1M | 0.37% |
| 20 | ACRIVON THERAPEUTICS INC | ACRV | 405,237 | $976,622 | 0.33% |
| 21 | VYNE THERAPEUTICS INC | VYNE | 1,425 | $827 | 0.00% |